Skip to content
10-Q/A

Quarterly Report

COMPASS BIOTECHNOLOGIES INC.

0001185185-11-001665

← back to feed
Filed
Sep 29, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Sep 19, 2011 21.66M sh
Capex Q2 2011 · Jul 31, 2011 $2.91K
Operating Cash Flow Q2 2011 · Jul 31, 2011 −$72.18K
Operating Cash Flow Q2 2011 · Jul 31, 2011 −$1.77M
Operating Cash Flow Q2 2011 · Jul 31, 2010 −$157.74K
Cash And Equivalents Q2 2011 · Jul 31, 2011 $58
Cash And Equivalents Q2 2011 · Jan 31, 2011 $34.75K
Cash And Equivalents Q2 2011 · Jul 31, 2010 $1.37K
Cash And Equivalents Q2 2011 · Jan 31, 2010 $4.92K
Stockholders Equity Q2 2011 · Jul 31, 2011 −$151.09K
Stockholders Equity Q2 2011 · Jan 31, 2011 −$131.41K
Total Liabilities Q2 2011 · Jul 31, 2011 $875.03K
Total Liabilities Q2 2011 · Jan 31, 2011 $949.18K
Current Assets Q2 2011 · Jul 31, 2011 $67.06K
Current Assets Q2 2011 · Jan 31, 2011 $121.99K
Total Assets Q2 2011 · Jul 31, 2011 $723.94K
Total Assets Q2 2011 · Jan 31, 2011 $817.77K
Sga Expense Q2 2011 · Jul 31, 2011 $384.76K
Sga Expense Q2 2011 · Jul 31, 2011 $571.89K
Sga Expense Q2 2011 · Jul 31, 2011 $3.07M
Sga Expense Q2 2011 · Jul 31, 2010 $328.24K
Sga Expense Q2 2011 · Jul 31, 2010 $408.4K
Rd Expense Q2 2011 · Jul 31, 2011 $20.31K
Rd Expense Q2 2011 · Jul 31, 2011 $40.49K
Rd Expense Q2 2011 · Jul 31, 2011 $1.04M
Rd Expense Q2 2011 · Jul 31, 2010 $16.22K
Rd Expense Q2 2011 · Jul 31, 2010 $32.64K
Net Income Q2 2011 · Jul 31, 2011 −$423.33K
Net Income Q2 2011 · Jul 31, 2011 −$666.51K
Net Income Q2 2011 · Jul 31, 2011 −$4.61M
Net Income Q2 2011 · Jul 31, 2010 −$431.64K
Net Income Q2 2011 · Jul 31, 2010 −$544.63K
Operating Income Q2 2011 · Jul 31, 2011 −$444.83K
Operating Income Q2 2011 · Jul 31, 2011 −$691.77K
Operating Income Q2 2011 · Jul 31, 2011 −$4.63M
Operating Income Q2 2011 · Jul 31, 2010 −$360.69K
Operating Income Q2 2011 · Jul 31, 2010 −$473.68K